Alyssa Stiving

Merck & Co., Inc.

Dr. Alyssa Q. Stiving is a Senior Scientist in Analytical Research & Development at Merck & Co., Inc. based in West Point, PA. She obtained her B.S. in Chemistry (2015) from The Ohio State University and Ph.D. in Analytical Chemistry (2020) from the same institution under the guidance of Professor Vicki Wysocki. Her graduate research focused on using native mass spectrometry to study the structure of both soluble and membrane proteins. Her research also included MS instrument development, including surface-induced dissociation, ion mobility, and ultraviolet photodissociation. At Merck, she works on developing mass spectrometry methods to characterize vaccines and has had the opportunity to contribute to several programs including two Covid-19 live virus vaccine (LVV) candidates as well multiple other vaccine modalities including virus like particles (VLPs) and conjugate vaccines. She currently works on utilizing bottom-up proteomics to profile host cell proteins in support of vaccine process development, glycan analysis, PTM analysis, and native mass spectrometry.